This trial studies glucosamine and chondroitin in preventing inflammation in overweight patients. Chronic inflammation contributes to cancer formation, and biomarkers of inflammation have been associated with cancer risk. Glucosamine and chondroitin may prevent inflammation and this trial may help identify the bacteria that help process them in the gut.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Effects of glucosamine sulfate/chondroitin sulfate tablet (G&C) on gut microbial community modulation
Timeframe: Up to 2 years
Effects of G&C on serum C-reactive protein (CRP)
Timeframe: Up to 2 years